Trial Profile
Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Conbercept (Primary)
- Indications Choroidal neovascularisation
- Focus Therapeutic Use
- 09 Aug 2016 New trial record